PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
32.37%
Positive revenue growth while TSM is negative. John Neff might see a notable competitive edge here.
30.96%
Positive gross profit growth while TSM is negative. John Neff would see a clear operational edge over the competitor.
37.75%
Positive EBIT growth while TSM is negative. John Neff might see a substantial edge in operational management.
37.75%
Positive operating income growth while TSM is negative. John Neff might view this as a competitive edge in operations.
37.74%
Positive net income growth while TSM is negative. John Neff might see a big relative performance advantage.
No Data
No Data available this quarter, please select a different quarter.
33.33%
Positive diluted EPS growth while TSM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
27.59%
Share count expansion well above TSM's 11.36%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
6.33%
Diluted share count expanding well above TSM's 11.36%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-49.52%
Negative OCF growth while TSM is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-32.08%
Negative FCF growth while TSM is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
19.15%
AR growth of 19.15% while TSM is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
221.37%
Inventory growth of 221.37% while TSM is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
28.36%
Asset growth of 28.36% while TSM is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
-0.76%
We have a declining book value while TSM shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-63.33%
We’re deleveraging while TSM stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
24.19%
R&D growth of 24.19% while TSM is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
33.33%
SG&A growth of 33.33% while TSM is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.